Ion therapy of pulmonary fibrosis by inhalation of ionic solution derived from silicate bioceramics

Pulmonary fibrosis (PF) is a chronic and progressively fatal disease, but clinically available therapeutic drugs are limited due to efficacy and side effects. The possible mechanism of pulmonary fibrosis includes the damage of alveolar epithelial cells II (AEC2), and activation of immune cells such...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Tao, Zhang, Zhaowenbin, Weng, Dong, Lu, LiQin, Wang, XiaoYa, Xing, Min, Qiu, Hui, Zhao, MengMeng, Shen, Li, Zhou, Ying, Chang, Jiang, Li, Hui-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966967/
https://www.ncbi.nlm.nih.gov/pubmed/33778199
http://dx.doi.org/10.1016/j.bioactmat.2021.02.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966967/
https://www.ncbi.nlm.nih.gov/pubmed/33778199
http://dx.doi.org/10.1016/j.bioactmat.2021.02.013

Ejemplares similares